Medical Cannabis Firm Akanda Prices US$16 Million IPO

International medical cannabis firm Akanda Corp. (Nasdaq: AKAN) goes public today on the Nasdaq Capital Market. The firm priced its initial public offering, targeting to raise US$16.0 million.

The offering will consist of 4.0 million common shares priced at US$4.00 per share. The shares are expected to trade on the Nasdaq big board under the symbol “AKAN”.

The proceeds from the offering are intended primarily for property, plant and equipment, operations, working capital, and general corporate purposes.

The offering is expected to close on March 17, 2022, subject to customary closing conditions.

The cannabis firm was initially formed when Halo Collective Inc. (NEO: HALO) reorganized its non-US assets, Bophelo Bioscience & Wellness and Canmart. Akanda Executive Chairman Louisa Mojela previously served as the chairman of Halo Collective’s board prior to the reorganization.

Akanda then bought 100% of Bophelo and Canmart assets from Halo Collective in November 2021. Halo Collective stands as Akanda’s largest shareholder, owning 44% equity.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Questcorp Kicks Off Fully Funded Phase 2 Drilling at La Union

Cambria Gold Hits 483 g/t Gold in First Underground Infill Results at Premier

Related News

Singapore-Based A SPAC II Acquisition Prices US$185 Million IPO

Special purpose acquisition company A SPAC II Acquisition Corp. (Nasdaq: ASCBU) started trading on the...

Wednesday, May 4, 2022, 11:35:00 AM

Ex-Blue Origin President-Led SPAC C5 Acquisition Prices US$250 Million IPO

Blank check company C5 Acquisition Corporation (NYSE: CXAC.U) is looking to raise US$250 million for...

Monday, January 10, 2022, 04:46:00 PM

Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq...

Friday, July 9, 2021, 09:53:00 AM

Insurance Firm Ryan Specialty Group Looks To Raise US$1.3 Billion In IPO

Insurance provider Ryan Specialty Group Holdings priced its initial public offering as the company starts...

Thursday, July 22, 2021, 10:27:00 AM

Education SPAC Aetherium Acquisition Prices US$100 Million IPO

Special purpose acquisition company Aetherium Acquisition Corp. (Nasdaq: GMFIU) started trading publicly on the Nasdaq...

Thursday, December 30, 2021, 02:24:00 PM